Please login to the form below
BenevolentAI raises $115m to fund drug development
Its technology could cut the early stage drug discovery process by four years, says the company
Rigel and Ultragenyx claim approvals for rare drugs
Tavalisse and Crysvita are set to treat patients with chronic ITP and XLH, respectively
Amgen and Novartis migraine drug hits the mark again
Aimovig will become the first CGRP receptor-targeting drug if it reaches market
Merck’s Keytruda meets survival challenge in NSCLC
Data showed that almost 70% of patients on the combo were still alive after 12 months
AZ makes case for first-line Tagrisso therapy in lung cancer
Data shows the drug improved PFS versus older EGFR inhibitors including Roche’s Tarceva
Pfizer’s plans for Inlyta go awry with failed adjuvant trial
Interim data suggested there was no improvement on disease-free survival compared to placebo
Merck’s Keytruda scores in frontline lung cancer yet again
Drug improved overall survival as a monotherapy, which rival BMS’ Opdivo was unable to show
AbbVie’s upadacitinib aces phase III trial
Arthritis drug outperformed both placebo and Humira in the study
Incyte/Merck trial failure bodes ill for IDO class
The much-touted cancer immunotherapy combination fails to show improvement over Keytruda alone
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
Novartis buys gene therapy firm AveXis for $8.7bnLead candidate AVXS-101 could potentially replace regular drug treatment for SMA with a one-off intervention
-
Health insurers will test blockchain for data handlingAims to make health records more accurate and reliable
-
Life science companies can’t keep up with technology competitors The industry must look beyond novel drugs and devices, warns report
-
Another Tecentriq win for Roche as Avastin combo boosts survivalThe Swiss pharma group reported a 38% improvement in PFS in NSCLC patients
-
AbbVie slumps on trial results for would-be blockbuster Rova-TThe pharma group saw its shares plummet after the news broke
-
IMI calls for advancements in machine learning and digital clinical trialsWill reserve up to €82m for universities, SMEs and patient organisations
-
Novo Nordisk’s semaglutide obesity trial hits the markThe injection helped adults lose up to 13.8% of their body weight in a year
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
-
Metrion Biosciences establishes scientific advisory board
The board will provide scientific oversight and strategic advice to Metrion
-
Dr Sotirios Stergiopoulos leaves Shire for IpsenHe becomes the French biopharma’s chief medical officer
-
Linda Law joins Advicenne as US VP, clinical development and med affairsShe will oversee the biopharma’s developments with its dTRA candidate
-
Dr Fiona Marshall heads up MSD's new UK research facility She will be based in London and focus on early bioscience discovery
Latest research appointments
Featured jobs
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Senior Programme Executive
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and bebefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Account Manager – Med Comms – London
-
Salary TBC
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Scientific Director
-
Great salary and bebefits
Subscribe to our email news alerts
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- No incentive for a cure
- The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
Quick links
Infographics
